Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis
Clinical trial NCT05278338 · UNKNOWN
Trial details
- NCT number
- NCT05278338
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-21
- Primary completion
- 2023-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.